5 Chinese Stocks with the Biggest Gains This Week—Is Now the Right Time to Invest?

As the Chinese stock market continues to reflect mixed domestic economic indicators, with a GDP growth of 5% and inflation at 1%, specific sectors are showing high volatility and substantial growth opportunities. 

If you are tracking the best Chinese stocks or looking for the top gainers this week, the market presents a complex but rewarding landscape. 

This article breaks down the performance of five notable Chinese stocks, analyzing their recent gains and broader market potential to answer the pressing question: is now the right time to invest in China stocks?

Key Takeaways

• Success in the current Chinese stock market depends heavily on targeted stock picking within high-growth sectors rather than relying on broad index performance.
• Companies tied to green energy and specialized manufacturing, like Wuxi Xinhongye and Shandong Rike, are currently showing the strongest upward momentum.
• Investors must carefully manage risk when looking at Chinese stocks, as even top performers can exhibit high volatility and massive market caps do not guarantee positive returns.

5 Chinese Stocks with Biggest Gains this Week

Tracking the top gainers in the Chinese equity market reveals strong momentum in specialized sectors like electrical products, biotechnology, and chemicals. 

While broader indices navigate macroeconomic headwinds, these five companies have demonstrated significant price movements, making them key targets for investors seeking the top Chinese stocks.

1. Wuxi Xinhongye Wire and Cable (SZSE:301310)

Wuxi Xinhongye Wire & Cable has delivered explosive growth, boasting an 87.35% increase over the past month and an exceptional 113.18% gain over the last year. 

Operating in the electrical products sector, specifically manufacturing special cables for photovoltaic systems and new energy vehicles, the company has capitalized heavily on China's push for green infrastructure.

Currently holding a market capitalization of approximately 8.09 billion CNY, technical indicators point to a "Strong Buy." However, investors must factor in its high volatility rate of 16.44%. 

The stock recently experienced a daily jump of over 11%, indicating strong, aggressive momentum that aggressive growth investors look for in China stocks to buy now.

2. Anhui Wanbang Pharm Tech (SZSE:301520)

Anhui Wanbang Pharmaceutical Technology has surged with a 34.95% increase over the last month, demonstrating strong resilience in the biotechnology sector. 

The company, which provides specialized pharmaceutical R&D outsourcing services, has seen a 15.88% gain over the past year.

With a market cap of roughly 2.91 billion CNY, Anhui Wanbang currently carries a "Strong Buy" consensus based on technical setups. 

Like Wuxi Xinhongye, it exhibits high volatility (15.06%), which was evident in a recent single-day spike of over 13%. 

Read Also: BIO Crypto Surges 25%: Is Big Pharma News Behind It?

This suggests strong short-term trading interest, making it a focal point for those analyzing what the best Chinese stock to invest in within the healthcare space.

3. Shandong Rike Chemical (SZSE:300214)

Shandong Rike Chemical has shown robust and consistent upward momentum, recording a 31.07% gain in the past month and a 50.96% increase year-over-year. 

As a major diversified chemicals producer specializing in plastic modifiers, the company is benefiting from steady industrial demand.

Valued at approximately 4.70 billion CNY, the stock is currently rated as a "Strong Buy." 

Its steady 5-year growth trajectory of over 46% positions it as a potentially more stable growth play compared to the highly volatile biotech and energy sectors, appealing to investors looking for solid fundamental performance in the China stock market.

4. Bestechnic (SSE:688608)

Despite being the largest company on this list with a market cap of 27.47 billion CNY, Bestechnic’s recent performance highlights the struggles within specific segments of the semiconductor industry. 

The stock managed a marginal 1.41% gain over the last month but remains down 29.22% over the past year.

Specializing in smart audio SoC (System on a Chip) designs for AI IoT devices, Bestechnic faces broader industry headwinds. Technical indicators currently lean toward a "Sell." 

For those conducting China stock market analysis, Bestechnic serves as a cautionary tale that heavy market capitalization does not guarantee short-term positive momentum, though it remains a significant ETF holding.

5. Gansu Longshenrongfa Pharm (SZSE:300534)

Gansu Longshenrongfa Pharmaceutical represents the weaker side of recent market movements, experiencing a 6.56% decline over the past month and a 23.21% drop over the last year. 

Operating in the traditional Chinese medicine and broader pharmaceutical space, the company has struggled to find growth momentum.

With a market cap of 2.15 billion CNY, the current technical consensus is a "Sell." 

Despite the broader healthcare sector seeing pockets of growth (like Anhui Wanbang), Gansu Longshenrongfa’s performance indicates that stock selection within Chinese healthcare requires careful, company-specific analysis rather than broad sector investments.

Why Invest in Chinese Stocks? - Market Analysis

Investing in Chinese stocks right now requires navigating a landscape defined by targeted government stimulus, massive ETF inflows, and a pivot toward high-tech and green energy sectors. 

The broader market environment, highlighted by a 5% GDP growth, shows that while traditional sectors may lag, specialized industries are thriving.

The performance of companies like Wuxi Xinhongye and Anhui Wanbang underscores the market's appetite for innovation and infrastructure. 

Furthermore, heavy ETF activity in sectors like semiconductors and traditional Chinese medicine indicates sustained institutional interest. 

Read Also: Guide to Trading TradFi Assets on Bitrue 2026

For investors willing to look past broad index performance and focus on specific, high-growth sectors, the Chinese market offers substantial alpha-generation opportunities.

Is Chinese Stocks Good to Buy Now?

Determining if Chinese stocks are good to buy now depends entirely on your risk tolerance and sector focus. If you are looking at broad indices, the recovery appears mixed. 

However, if you are targeting specific industries like new energy vehicle supply chains (Wuxi Xinhongye) or specialized biotech R&D (Anhui Wanbang), the momentum is undeniably strong.

The key to success in the current environment is avoiding generalized exposure and instead focusing on stocks with strong technical setups and clear catalysts. 

The high volatility seen in the top gainers means timing and risk management are critical, but the upside potential remains significant for carefully selected assets.

Final Note

The Chinese stock market is currently a stock-picker's environment. 

While macroeconomic factors present a mixed picture, individual stocks like Wuxi Xinhongye Wire & Cable and Shandong Rike Chemical are delivering massive gains, driven by sector-specific tailwinds. 

Conversely, heavyweights like Bestechnic remind investors that caution is still required.

The information provided in this article is for educational and informational purposes only and does not constitute financial or investment advice. 

The stock market is inherently volatile, and past performance is not indicative of future results. Always conduct your own due diligence or consult with a licensed financial advisor before making investment decisions.

FAQ

Are Chinese stocks a good investment right now?

Investing in Chinese stocks currently offers a mixed but potentially highly rewarding landscape. While broader market indices face macroeconomic headwinds, specific sectors like green energy infrastructure, biotechnology, and specialized chemicals are experiencing massive gains. Success in the current Chinese market relies on targeted stock picking rather than broad index investing, making it a good investment if you focus on companies with strong technical momentum.

What are the best Chinese stocks to buy for quick gains?

The best Chinese stocks for rapid growth are currently found in specialized industrial and tech sectors. Recent top performers include Wuxi Xinhongye Wire & Cable (SZSE:301310) and Shandong Rike Chemical (SZSE:300214), which have shown exceptional 1-month and 1-year gains. Investors should look for stocks with a "Strong Buy" technical consensus and direct ties to high-demand industries like electric vehicles and industrial manufacturing.

Why is Wuxi Xinhongye Wire & Cable stock going up so fast?

Wuxi Xinhongye Wire & Cable has surged over 113% in the past year due to its strategic position in the green energy supply chain. The company manufactures specialized cables for photovoltaic (solar) systems and new energy vehicles (NEVs). As China aggressively expands its green infrastructure and electric vehicle production, demand for Wuxi Xinhongye's specialized electrical products has skyrocketed, driving aggressive stock momentum.

Why are large Chinese semiconductor stocks like Bestechnic struggling?

Despite having large market capitalizations, some Chinese semiconductor companies like Bestechnic (SSE:688608) are underperforming due to broader industry headwinds, shifting domestic demand, and complex global supply chain dynamics. While they remain significant holdings for many ETFs, their short-term technical indicators currently lean toward a "Sell," proving that a massive market cap does not guarantee short-term price growth in the current economic climate.

Are Chinese biotech stocks safe for long-term investors?

Chinese biotech and pharmaceutical stocks offer high growth potential but come with significant volatility, requiring careful risk management. For instance, Anhui Wanbang Pharmaceutical Technology recently saw a massive single-day spike of over 13% and carries a volatility rate of over 15%. While this creates lucrative opportunities for short-term traders, long-term investors must be prepared for sharp price swings and conduct deep company-specific research before investing.

Disclaimer: The views expressed belong exclusively to the author and do not reflect the views of this platform. This platform and its affiliates disclaim any responsibility for the accuracy or suitability of the information provided. It is for informational purposes only and not intended as financial or investment advice.